Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

International PPL declares first dividend under new quarterly structure

(Sharecast News) - International Public Partnerships (INPP) declared its first interim dividend for 2025 on Friday, marking the start of a new quarterly payment structure aimed at providing investors with a more regular income stream. The FTSE 250 infrastructure investment company announced a dividend of 2.14p per share, with an ex-dividend date of 14 August, a record date of 15 August, and payment set for 15 September 2025.

It said the move to quarterly dividends was part of a wider portfolio optimisation strategy.

INPP said the change reflected its commitment to aligning its dividend policy with investor preferences for more frequent distributions, while maintaining full cash coverage of dividend payments.

The company reaffirmed its dividend targets for 2025 and 2026, which stood at 8.58p and 8.79p per share respectively.

INPP said it was still projecting a long-term annual dividend growth rate of around 2.5%, supported by the stable cash flows generated from its portfolio of infrastructure assets.

At 1240 BST, shares in International Public Partnerships were flat at 127.4p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.